3-(3,4-DIMETHYL-6-OXO-6H-PYRANO[2,3-C]PYRAZOL-1-YL)-BENZOIC ACID
![]() |
- $378 - $777.32
- Product name: 3-(3,4-DIMETHYL-6-OXO-6H-PYRANO[2,3-C]PYRAZOL-1-YL)-BENZOIC ACID
- CAS: 354557-58-7
- MF: C15H12N2O4
- MW: 284.27
- EINECS:
- MDL Number:MFCD01874300
- Synonyms:3-(3,4-DIMETHYL-6-OXO-6H-PYRANO[2,3-C]PYRAZOL-1-YL)-BENZOIC ACID;Benzoic acid, 3-(3,4-dimethyl-6-oxopyrano[2,3-c]pyrazol-1(6H)-yl)-;3-(3,4-Dimethyl-6-oxopyrano[2,3-c]pyrazol-1(6H)-yl)benzoic acid
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0084866
- Product description3-(3,4-DIMETHYL-6-OXO-6H-PYRANO[2,3-C]PYRAZOL-1-YL)-BENZOIC ACID 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11137177
- Product description3-(3,4-Dimethyl-6-oxopyrano[2,3-c]pyrazol-1(6H)-yl)benzoicacid 97%
- Packaging5g
- Price$701
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018607
- Product description3-(3,4-Dimethyl-6-oxo-6H-pyrano[2,3-c]pyrazol-1-yl)-benzoic acid
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0084866 | 3-(3,4-DIMETHYL-6-OXO-6H-PYRANO[2,3-C]PYRAZOL-1-YL)-BENZOIC ACID 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
Crysdot | CD11137177 | 3-(3,4-Dimethyl-6-oxopyrano[2,3-c]pyrazol-1(6H)-yl)benzoicacid 97% | 5g | $701 | 2021-12-16 | Buy |
Matrix Scientific | 018607 | 3-(3,4-Dimethyl-6-oxo-6H-pyrano[2,3-c]pyrazol-1-yl)-benzoic acid | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :549.7±50.0 °C(Predicted)
Density :1.41±0.1 g/cm3(Predicted)
pka :3.77±0.10(Predicted)
Density :1.41±0.1 g/cm3(Predicted)
pka :3.77±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|